Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

SHE:300204 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,460	3,540	4,854	6,419	8,242	4,241
Market Cap Growth	286.37%	-27.07%	-24.38%	-22.12%	94.35%	-18.80%
Enterprise Value	12,333	3,498	4,711	6,113	7,806	3,550
Last Close Price	26.08	7.41	10.16	13.60	17.55	9.03
Forward PE	-	78.50	78.50	78.50	78.50	78.50
PS Ratio	50.99	10.90	13.33	11.69	14.11	9.97
PB Ratio	14.49	3.86	4.76	4.74	5.32	2.67
P/TBV Ratio	15.30	4.05	5.03	5.12	5.70	2.86
EV/Sales Ratio	50.47	10.77	12.94	11.14	13.36	8.35
EV/FCF Ratio	-69.54	-	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.04	0.02	0.01	0.03
Asset Turnover	0.19	0.26	0.24	0.31	0.32	0.23
Inventory Turnover	2.13	2.89	3.75	4.64	3.69	1.74
Quick Ratio	1.65	0.61	0.71	1.96	3.18	4.09
Current Ratio	2.46	1.15	1.15	2.28	3.50	4.34
Return on Equity (ROE)	-18.63%	-15.25%	-33.60%	-13.56%	-8.76%	-8.25%
Return on Assets (ROA)	-3.55%	-2.24%	-15.56%	-8.36%	-8.13%	-6.38%
Return on Invested Capital (ROIC)	-8.74%	-4.73%	-35.68%	-21.17%	-23.89%	-21.02%
Return on Capital Employed (ROCE)	-6.30%	-4.50%	-33.20%	-16.30%	-14.70%	-11.50%
Earnings Yield	-1.33%	-4.09%	-8.22%	-3.07%	-1.67%	-3.14%
FCF Yield	-1.42%	-2.46%	-5.37%	-3.62%	-2.65%	-3.85%
Buyback Yield / Dilution	-9.55%	-1.67%	1.17%	-1.42%	0.27%	-4.41%
Total Shareholder Return	-9.55%	-1.67%	1.17%	-1.42%	0.27%	-4.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.